Study on the clinical and mechanism of ''Tiaoshen liqi'' acupuncture in the treatment of mild depressio

Phase 1

Recruiting

• Conditions: mild depression

• Registration Number: ITMCTR2200006378
• Lead Sponsor: The First Affiliated Hospital of Heilongjiang University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria for mild depression of the International Classification of Diseases 10th revision (ICD-10).
2. Aged between 18 and 70 years.
3. The score of HDRS-24: 20 =HDRS= 26.
4. Patients who have not participated in other clinical trials within the last 1 month.
5. Patients who have not received treatment such as acupuncture and medication for depression within the last 1 week.
6. Patients who do not have aphasia or mental retardation, can understand the content of the scale and cooperate with 4 weeks of acupuncture treatment and follow-up for 3 months and sign an informed consent form.

Exclusion Criteria

1. Meet the diagnostic criteria for schizophrenia, bipolar depression or other psychotic disorders with suicidal tendencies.
2. Patients with severe heart, liver, kidney and other systemic diseases.
3. Pregnant or lactating women.
4. Patients who cannot tolerate needling, or who have skin infection or breakdown at the site of needling, coagulation disorders, easy to get dizzy, or extreme weakness.
5. Patients who have participated in other clinical trials within 1 month prior to the start of this study.
6. Patients who have taken antidepressants or received acupuncture treatment for depression within 1 week prior to the start of this study.
7. Patients with severe cognitive and consciousness impairment that affects communication and unwillingness to cooperate, and who have not signed the informed consent form.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HDRS-24;

Secondary Outcome Measures

Name	Time	Method
PHQ-9;WHOQOL-BREF;